Equities

Agape ATP Corp

AATP:PKC

Agape ATP Corp

Actions
  • Price (USD)7.50
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation. The Company is engaged in providing health solution advisory services on combining these nine products for the client’s diseases. ATP Zeta Super Health Program is focused upon biological energy, Adenosine Trisophate (ATP), at the cellular level. ATP Zeta Super Health Program includes Body Detoxification, Cell Repairing and Rejuvenation and Cell Protection. Body Detoxification reduces toxin accumulation and prevents cells from further damage. Cell Repairing and Rejuvenation replaces aging cells. Cell Protection activates the immune cells to build internal and external protection of the body’s cells. The ATP Zeta Super Health Program consists of nine products, including ATP1s Survivor Select, ATP2 Ene.Mineral Concentrate, ATP 3 Ionized Cal-Mag, ATP4 Omega Blend, ATP5 BetaMaxx, AGN-Vege Fruit Fiber, AGP1-Iron, YFA-Young Formula and ORYC-Organic Youth Care Cleansing Bar.

  • Revenue in USD (TTM)3.13m
  • Net income in USD29.66k
  • Incorporated2016
  • Employees--
  • Location
    Agape ATP Corp0KUALA LUMPUR 58100MalaysiaMYS
  • Phone+60 327325716
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AATP:PKC since
announced
Transaction
value
Agape Superior Living Sdn BhdAnnounced08 May 202008 May 2020Announced0.00%1.72m
Data delayed at least 15 minutes.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Evolent Health Inc987.04m-520.82m1.52bn3.40k--2.36--1.54-6.15-6.1111.647.480.6356--11.46290,304.40-33.67-5.60-42.86-7.0931.1041.45-52.97-14.91---4.160.3034--34.98---470.21------
Surgery Partners Inc1.83bn-191.20m1.56bn6.90k--15.3935.160.8517-3.93-3.6837.6110.410.357628.715.71265,072.50-0.70181.17-0.98881.6525.2029.93-1.962.841.431.140.6485--3.3835.3453.60--50.81--
U.S. Physical Therapy, Inc.427.62m30.12m1.65bn5.40k54.736.2329.153.862.352.3533.3720.620.7498--8.0079,188.348.049.4913.0713.9022.5022.8710.738.95--49.020.029948.836.189.5888.3010.3214.5518.89
Pennant Group Inc372.48m7.93m1.70bn4.70k235.7618.94137.644.550.25530.255312.673.180.8836--11.2779,250.641.88--2.28--24.77--2.13----14.040.0077--18.34---83.77------
CorVel Corporation560.75m41.27m1.90bn3.82k47.159.4233.023.402.262.2630.6711.301.29--7.76146,638.309.5013.5214.0821.1120.8720.497.366.65----0.00---0.5903.752.6810.637.19--
Addus Homecare Corporation758.82m34.67m1.92bn5.00k55.803.7841.072.532.182.1847.6432.121.15--5.91151,703.505.285.366.066.6129.3027.034.573.32--20.960.1083--25.5815.7058.2816.63-2.61--
MEDNAX Inc2.22bn18.92m2.05bn5.17k103.212.5434.670.92160.2319-8.6526.699.410.5762--5.84430,338.000.49030.29040.56250.3204----0.8510.4587--2.540.6843--1.707.57-544.72--12.04--
Genetron Holdings Ltd - ADR60.74m-483.29m2.07bn663.00--2.44--34.14-16.36-16.362.039.620.30988.344.17---246.46---315.23--56.40---795.62--5.68-0.09160.0587--43.63---45.39------
Magellan Health Inc5.20bn49.33m2.45bn10.10k48.121.5414.370.47181.975.32206.5561.671.59116.436.41514,379.001.512.202.223.313.623.810.94950.96432.053.100.28890.00-2.1213.75128.02-6.78-0.6287--
BioTelemetry Inc438.83m17.68m2.47bn1.70k148.806.2137.885.620.48320.483212.0011.570.62128.156.79258,134.702.506.712.757.5361.7461.714.038.172.727.320.28540.009.9221.39-30.30--19.16--
Agape ATP Corp3.13m29.66k2.82bn--107,142.90490.165,230.44902.170.000070.000070.00830.01530.5385--6.91--0.5103--0.5644--73.43--0.9477--5.47--0.00--------------
Accolade Inc155.57m-48.07m3.03bn1.24k--7.79--19.45-1.13-1.133.487.040.5801--18.14124,453.60-17.92---24.65--43.43---30.90-----9.560.00--39.76--9.08------
Veracyte Inc112.68m-34.32m3.09bn354.00--7.30--27.44-0.6819-0.68192.217.310.31547.305.46318,296.60-9.61-24.13-10.04-27.6064.1663.71-30.46-33.0126.28-138.730.0018--30.8225.8145.22--6.37--
Option Care Health Inc2.95bn-41.73m3.54bn5.08k--3.5694.951.20-0.2371-0.237116.525.321.1217.188.97580,333.80-1.59-11.52-1.86-14.1222.8626.89-1.42-8.071.200.73010.5412--225.9120.15-20.89--15.39--
Burning Rock Biotech Ltd(ADR)59.72m-69.42m3.69bn753.00--9.26--61.81-0.6821-0.68210.58683.840.2091.883.8584,710.92-18.69---21.06--69.73---89.40--9.59--0.0177--82.74---43.82------
Select Medical Holdings Corporation5.45bn206.43m3.85bn35.70k17.973.717.820.70731.591.5941.987.710.7352--6.64152,543.503.863.095.314.1014.8114.295.253.45--3.420.6592.137.3312.227.634.1110.53--
Data as of --. Currency figures normalised to Agape ATP Corp's reporting currency: US Dollar USD
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.